Latest documents

Some of these documents might not be available in your language, so another language version will be suggested automatically. These are shown by an icon representing the suggested language version. (e.g.: FR ).

Stress-testing to promote the resilience of EU policies

12-05-2023 PE 734.710 COVI TRAN
Study
Summary : Stress-testing is a promising foresight policy tool that can support the design of EU policies able to withstand the shocks and challenges of both the present day and the years to come. This study explores how the European Parliament could use stress-tests to identify weak points in EU legislation and avenues for further EU action. The study draws on the findings of a stress-test of EU rail transport policy and recommendations from an expert practitioner of foresight and regulatory policy. It finds that stress-tests across different policy areas could boost the European Parliament's role as co-legislator in the European Union, especially in the agenda-setting and law-making phases of the legislative cycle.
Authors : ALEKSANDRA HEFLICH, MEENAKSHI FERNANDES

Mapping of long-term public and private investments in the development of Covid-19 vaccines

29-03-2023 PE 740.072 COVI
Study
Summary : This study provides a mapping of funds contributed by different actors for the R&D and the expansion of the production capacity of COVID-19 vaccines, with a focus on those authorised in the EU. Nine vaccines are examined. It is found that governments, mainly the US (with some not-for-profit entities) decisively supported corporate investments, either for R&D, manufacturing, or both, by nearly EUR 9 billion, i.e. on average EUR one billion of grants per vaccine, with, however, vast variance across companies. Moreover, almost EUR 21 billion was allocated to companies through Advance Purchase Agreements. While the EU and MS support through Advance Purchase Agreements was key to de-risk the production of vaccines, the role of EU and MS support in directly supporting R&D was marginal compared with the US federal government. The study assesses the necessity for continuing public support to R&D on vaccines for SARS-CoV-2 future variants of concern and possibly other coronaviruses. After highlighting current market failures, new incentive mechanisms in the public interest for vaccine R&D are suggested to grant equity and accessibility, as well as rewards in line with risks.
Authors : Massimo FLORIO, Simona GAMBA, and Chiara PANCOTTI

Workshop on COVID-19: EU Crisis Preparedness and Response

17-03-2023 PE 740.074 COVI
Study
Summary : These proceedings summarise the presentations and discussions during the workshop on ‘COVID-19: EU Preparedness and Response’, held on 8 March 2023. The five presentations touched, inter alia, upon the impact of COVID-19 at EU level, and how the EU has been prepared, how it responded to that crisis, and the lessons learned following the pandemic. These workshop proceedings were provided by the Policy Department for Economic, Scientific and Quality of Life Policies for the Special Committee on COVID-19 pandemic: lessons learned and recommendations for the future (COVI).
Authors : Julia LIETZMANN and Loreleï LEMETAYER

Social and Economic Consequences of COVID-19

01-03-2023 PE 740.079 COVI
At a Glance
Summary : The original full study considers the consequences of measures aimed at countering the effects of COVID-19, in particular the Temporary Framework for State aid, EU Digital COVID Certificates and other measures implemented by EU Member States. The study examines the consequences of the measures on industry, small and medium-sized enterprises (SMEs) and focuses on the cultural and creative industries. Consequences for workers and working practices are also considered, and lessons learnt identified.
Authors : Jan SMIT, Elias NACER, Andrew SIKORSKI, Caroline GODARD and Wiktor MAGDZIARZ

Social and Economic Consequences of COVID-19

01-03-2023 PE 740.071 COVI
Study
Summary : This study considers the consequences of measures aimed at countering the effects of COVID-19, in particular the Temporary Framework for State aid, EU Digital COVID Certificates and other measures implemented by EU Member States. The study examines the consequences of the measures on industry, small and medium-sized enterprises and focuses on the cultural and creative industries. Consequences for workers and working practices were also considered, and lessons learnt identified. This document was provided by the Policy Department for Economic, Scientific and Quality of Life Policies at the request of the special committee on COVID-19 pandemic: lessons learned and recommendations for the future (COVI).
Authors : Jan SMIT, Elias NACER, Andrew SIKORSKI, Caroline GODARD and Wiktor MAGDZIARZ

Workshop on long COVID - Workshop Proceedings

01-03-2023 PE 740.077 COVI
Study
Summary : These proceedings summarise the presentations and discussions of the workshop on ‘long COVID’ organised for the European Parliament’s Special Committee on the COVID-19 pandemic on 9 March 2023. The six presentations touched, inter alia, upon the current state of knowledge on the disease’s clinical profile, potential causes and underlying mechanisms, impacts on patients and society, and lessons to be learned from post-acute infection syndromes and chronic diseases. The speakers and Members could discuss the urgent actions and financial support needed from the EU to close gaps in scientific knowledge, to raise awareness on long COVID, and to develop treatments which could improve patients’ condition.
Authors : Maxime MOULAC, Milieu Consulting SRL.

The European public health response to the COVID-19 pandemic: Lessons for future cross border health threats

17-02-2023 PE 740.218 COVI
Study
Summary : This study was drawn up to support the work of the European Parliament's Special Committee on the COVID 19 pandemic. It examines the European Union's public health response to the COVID 19 pandemic across the following five pillars: (1) the EU vaccines strategy and national vaccination strategies; (2) independent scientific evidence on vaccine effectiveness; (3) the EU public health response to COVID 19, addressing the EU framework for crisis response; (4) the EU's prevention and preparedness efforts for future health threats; and (5) considerations regarding EU competences in public health. By assessing the lessons of the COVID 19 pandemic, the current state of play, challenges, and opportunities for improvement in EU public health governance, a series of recommendations are proposed to strengthen the EU's resilience and preparedness for future cross-border health threats.
Authors : Irmgard ANGLMAYER, Susanna TENHUNEN

Policy Departments’ Monthly Highlights - February 2023

At a Glance
Summary : The Monthly Highlights publication provides an overview, at a glance, of the on-going work of the policy departments, including a selection of the latest and forthcoming publications, and a list of future events.

THE EFFECT OF COMMUNICATION AND DISINFORMATION DURING THE COVID-19 PANDEMIC

08-02-2023 PE 740.065 COVI
At a Glance
Summary : This study analyses how governments, public health experts and other professionals communicated during the COVID-19 pandemic, and the impact of these communication strategies. It investigates COVID-19 misinformation and disinformation practices, and how these practices were addressed in the European Union by the Member States and the European Commission. It draws up recommendations to improve responses in the future, including by analysing the role of the Code of Practice on disinformation ad the expected impact of the Digital Services Act.
Authors : Cécile JACOB, VVA Brussels Pierre HAUSEMER, VVA Brussels Adam ZAGONI-BOGSCH, VVA Brussels Dr. Audra DIERS-LAWSON, Kristiania University College

Intersectional evaluation of the impact of the COVID-19 pandemic on different groups

01-02-2023 PE 740.073 COVI
Study
Summary : This study examines the intersections between COVID-19, mental health and socioeconomic stressors in the lives of adolescents and young people, the impact of COVID-19 measures, including lockdowns, on children and vulnerable people, and efforts to tackle violence against women and domestic violence in Europe during the COVID-19 pandemic. This document was provided by the Policy Department for Economic, Scientific and Quality of Life Policies at the request of the Special Committee on the COVID-19 pandemic: lessons learned and recommendations for the future (COVI).
Authors : Hana ŠPÁNIKOVÁ, Maxime MOULAC, Panagiota PAVLOU, Laura VONA, and Linus SIÖLAND; Milieu Consulting SRL

THE EFFECT OF COMMUNICATION AND DISINFORMATION DURING THE COVID-19 PANDEMIC

26-01-2023 PE 740.063 COVI
Study
Summary : This study analyses how governments, public health experts and other professionals communicated during the COVID-19 pandemic, and the impact of these communication strategies. It investigates COVID-19 misinformation and disinformation practices, and how these practices were addressed in the European Union by the Member States and the European Commission. It draws up recommendations to improve responses in the future, including by analysing the role of the Code of Practice on disinformation ad the expected impact of the Digital Services Act.
Authors : Cécile JACOB, VVA Brussels Pierre HAUSEMER, VVA Brussels Adam ZAGONI-BOGSCH, VVA Brussels Dr. Audra DIERS-LAWSON, Kristiania University College

Parliamentary oversight of governments' response to the COVID-19 pandemic: Literature review

25-01-2023 PE 740.217 COVI
Study
Summary : Conducted at the request of the European Parliament's Special Committee on the COVID 19 pandemic, this literature review examines the patterns in, consequences of and correlation between national approaches to parliamentary oversight of governments' responses to the COVID 19 pandemic in the EU27 and four other countries (Canada, Switzerland, the United Kingdom and the United States). The review begins by assessing parliaments' involvement during the early stages of the health crisis, when many countries were operating under emergency regimes or statutory frameworks that provided for rapid action. It then maps the parliaments' law-making and oversight role during the pandemic, demonstrating that they were not necessarily side-lined. The study goes on to assess successes and failures and, on that basis, factors in the resilience of parliamentary oversight. Mapping the widespread use of sunset and review clauses in emergency legislation, the study reflects on parliaments' cooperation with supreme audit institutions and independent fiscal institutions, which enhanced their budgetary oversight role during the pandemic. The literature review also identifies best practice regarding oversight during the COVID 19 pandemic and reforms that parliaments could pursue to strengthen their preparedness for future crises.
Authors : Irmgard ANGLMAYER, Susanna TENHUNEN

Policy Departments’ Monthly Highlights - January 2023

At a Glance
Summary : The Monthly Highlights publication provides an overview, at a glance, of the on-going work of the policy departments, including a selection of the latest and forthcoming publications, and a list of future events.

Towards a new EU pharmaceutical strategy

15-12-2022 PE 737.129 COVI ENVI ITRE IMCO
At a Glance
Summary : The European Commission plans to launch its revised EU pharmaceutical package in the first quarter of 2023. Ahead of its release, two recent STOA studies offer insight to inform upcoming Parliamentary discussions. Fragmentation of EU health research and development, lack of transparency and a translation gap between public investment and clinical output are among the weaknesses identified. Possible solutions include the creation of large-scale European biomedical infrastructure, and a series of targeted strategies to improve EU health research coordination and reprioritise areas of unmet therapeutic need.
Authors : LUISA ANTUNES

Impact of COVID-19 measures on democracy and fundamental rights - Best practices and lessons learned in the Member States and third countries

12-12-2022 PE 734.010 COVI
Study
Summary : This research study examines the impact of COVID-19 measures on democracy and fundamental rights in the EU. It considers what best practices have been evidenced, and the lessons that can be learned from comparative experience within EU Member States as well as relevant third countries. It examines pandemic governance in the EU and its Member States during the COVID-19 pandemic between 2020 and 2022. It describes how the COVID-19 pandemic was addressed by EU Member States, either in terms of declaring a state of emergency or similar regimes, or using emergency powers or emergency health legislation, or normal legislation. This study was provided by the Policy Department for Economic, Scientific and Quality of Life Policies at the request of the special committee on the COVID-19 pandemic: lessons learned and recommendations for the future (COVI).
Authors : Joelle GROGAN, CEU Democracy Institute, Hungary

C transfers in the EP’s budget in 2020 - response to the COVID-19 crisis

23-11-2022 PE 702.617 COVI BUDG CONT
Briefing
Summary : The EP’s budget is drawn up during the year n-1, with the preparations in its Directorates General already starting in the last quarter of the year n-2. The budgetary procedure - first inside the EP for the institution’s own budget, then for the budget of the EU as a whole in the interinstitutional part of the procedure - lasts throughout the year n-1, with an agreement usually reached during the last quarter of year n-1. For example, the preparations for the 2020 budget in the Directorates General started towards the end of 2018, with the main budgetary process taking place in 2019.
Authors : Michaela FRANKE

Policy Departments’ Monthly Highlights - November 2022

At a Glance
Summary : The Monthly Highlights publication provides an overview, at a glance, of the on-going work of the policy departments, including a selection of the latest and forthcoming publications, and a list of future events.

What if a 'Trojan horse' strategy could help address antimicrobial resistance?

16-11-2022 PE 729.544 COVI ENVI IMCO
At a Glance
Summary : Antimicrobial-resistant infections are predicted to become the second biggest cause of death worldwide by 2050. Despite increasing investment in the development of new antimicrobials, awareness campaigns on antimicrobial misuse and abuse, and monitoring of antimicrobial use and resistance in animals, humans and the environment, antimicrobial resistance continues to grow and the last three decades have not seen even one novel antimicrobial class reach the market. Could the answer lie in a 'Trojan horse' strategy to disrupt a natural physiological process common to all bacteria?
Authors : LUISA ANTUNES

C and P transfers in the EP’s budget in 2021 – in the wake of the COVID-19 crisis

15-11-2022 PE 739.133 COVI CONT BUDG
Briefing
Summary : This briefing analyses C and P transfers in the EP’s budget during 2021. It differentiates between transfers linked directly and indirectly to the EP’s response to the COVID-19 crisis on the one hand and those that dealt with other, unrelated, needs on the other, including the EP’s building policy. A comparison between the main tendencies observed in 2020 and 2021 sheds light on the impact the COVID-19 crisis had on the EP’s budget in both years.
Authors : Michaela FRANKE

COVID-19 response of EU public administration

10-06-2022 PE 733.411 COVI BUDG CONT
Study
Summary : In order to provide the Members of the Budgetary Control Committee with reliable information and data on the COVID-19 response of the EU public administration, the study analyses the EU institutions’ response, their business continuity measures and their impact on the budget from 2020 onwards and staff of the respective institution. Furthermore, the study provides an overview of practices and challenges around the new working modalities EU institutions are adopting for the post-pandemic future, as well as recommendations for the way forward.
Authors : Alessandro VALENZA, Dea HRELJA, Pietro CELOTTI, Caterina CASAMASSIMA, Michele ALESSANDRINI, Roland BLOMEYER, Nicolò FRANCESCHELLI
Document type

Executive summary